perpetual futures regulatory dispute (perps) — On June 21, 2026, CME Group filed a lawsuit against the Commodity Futures Trading Commission seeking to challenge and vacate the agency’s approval of Kalshi’s perpetual futures contracts. The lawsuit was filed a day after outgoing CEO Terrence Duffy announced he would file suit over the CFTC’s approval granted at the end of May, and the complaint centers on the agency’s handling of Kalshi’s newly approved perps. Perpetual futures are a relatively new product type with substantial participation from the crypto industry.
CME’s lawsuit alleges that the CFTC’s approval process for Kalshi’s perpetual futures contracts violated the Dodd-Frank Act by failing to follow required procedural and legal analysis, and it frames these procedural deficiencies as central to the challenge. The filing asserts that the agency did not conduct its own evaluation of the legal status of the product, stating, “The CFTC did not engage in its own analysis of whether its approval of Kalshi’s Bitcoin perpetual as a future is consistent with law.”
The complaint also highlights the agency’s omission of key statutory language, stating, “The CFTC did not even mention the relevant Dodd-Frank provision defining ‘swap.’ Indeed, the word ‘swap’ appears nowhere in the Order.”
The suit alleges that the CFTC allegedly rubberstamped Kalshi’s application without independent review and that the agency’s handling of the submission constituted a procedural lapse identified in the complaint. CME argues in the filing that the approval of perps harms its long-dated futures products, the complaint states explicitly. CME asks a court to vacate the approval and the self-certified products listed in the CFTC’s Order therein.
The CFTC granted approval for Kalshi’s perpetual futures at the end of May, a regulatory action the article records as occurring at that time. On the same day the agency granted Kalshi’s application, it also sent a no-action letter to Coinbase, a separate communication the article says could permit Coinbase to list perpetual futures through an offshore intermediary. The contemporaneous approval and no-action letter are presented in the article as linked regulatory moves that broaden access to perps beyond Kalshi’s platform.
The article describes perpetual futures as a novel product not clearly contemplated by the Dodd-Frank Act, a legal point that the complaint highlights as central to the regulatory dispute. That novelty and its legal treatment under existing statutes are identified in the article as core issues in the challenge to the approval process. Following the CFTC’s action, Kalshi’s approved contracts became listed as a Designated Contract Market product, the article notes.
The dispute between CME Group, the CFTC and Kalshi is a legal and regulatory conflict centered on the CFTC’s approval of Kalshi’s perpetual futures contracts and CME’s lawsuit seeking to vacate that approval. The case focuses on procedural and interpretive questions about the agency’s approval process and the statutory treatment of perpetual futures, with CME alleging defects in the approval procedures and regulatory interpretations.
